Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 5, 2026.

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

Emilia Kansanen, Suvi M. Kuosmanen, Hanna Leinonen and 1 more (opens in a new tab)

Redox Biology · 2013 · Review · CC BY-NC-ND

doi:10.1016/j.redox.2012.10.001 (opens in a new tab)

Abstract

The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy.

Shown for reading. Its publisher allows quoting it, not republishing it.

Cited by papers we hold 40

and 20 more

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.